← FDA Drug Approvals (Drugs@FDA)

EXEMESTANE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2019-02-21

Drug application

FDA Application #

ANDA211031

Application type

Abbreviated New Drug Application (Generic)

Brand name

EXEMESTANE

Generic name

EXEMESTANE

Active ingredients

EXEMESTANE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BRECKENRIDGE

Manufacturer

Breckenridge Pharmaceutical, Inc.

First approval

2019-02-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown